SunHo BioTech Group Ltd (SGSH)

SunHo BioTech Group Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0.91	1.54	0.31
Short-Term Investments	2.23	2.23	2.06
Cash & Cash Equivalents	3.14	3.77	2.37
Cash Growth	-	59.16%	-
Receivables	-	1.23	0.4
Inventory	-	0.12	0.11
Other Current Assets	-	0.07	0
Total Current Assets	-	5.19	2.88
Property, Plant & Equipment	-	0.1	0.03
Goodwill and Intangibles	-	16.86	18.99
Other Long-Term Assets	-	1.72	1.93
Total Long-Term Assets	-	18.68	20.95
Total Assets	-	23.86	23.83
Accounts Payable	-	0.82	0.72
Deferred Revenue	-	0.11	2.6
Current Debt	-	3.3	9.05
Other Current Liabilities	-	0.24	0.08
Total Current Liabilities	-	4.47	12.44
Long-Term Debt	-	5.05	9.21
Total Long-Term Liabilities	-	5.05	9.21
Total Liabilities	-	9.51	21.65
Total Debt	8.96	8.35	18.26
Debt Growth	-	-54.27%	-
Retained Earnings	-	-45.53	-42.75
Shareholders' Equity	14.17	14.35	2.18
Net Cash (Debt)	-5.83	-4.57	-15.89
Working Capital	-	0.72	-9.56

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).